Dr. Giuseppe Curigliano. Breast cancer therapy expert. Biography. 0
Leading expert in breast cancer therapy and new drug development, Dr. Giuseppe Curigliano, MD, explains the latest advances in treating HER2-positive, HER2-negative, and triple-negative breast cancer. He details the role of immunotherapy and the challenges in oncology drug development from his position as Director of New Drugs and Early Drug Development at the European Institute of Oncology in Milan.